Uccoordlight Biopharma Co. Ltd is established by Prof. Xizhi Guo of Shanghai Jiao Tong University in Feb., 2021, registered at Chongqing Liangjiang New Area with 1 million (RMB) funding and 20 millions first investment. Company located at Building 16, Dadi Enterprises Hub, Beibei, Chongqing, consisted with 500 m² research area, 800 m² GMP grade production area and 800m² work area.

The team of the company includes 8 personnel of research scientists with high education (Doctor degree), 10 personnel of production, 5 personnel of translational medicine and other 30 personnel of administration/finiance.

The company aims to develope the new generation of biopharmaceuticals based on stem cells. The primary product is the prime UMSCs that target diabetes, diabetic nephropathy and premature ovarian failure, as well as degenerative motor system diseases, such as osteoarthritis. The coming products aims to the third generation of stem cell medicine, novel biological molecules based on gene editing and delivered by exosomes and lentivirus-like particles.

Execetive Staff
Guo, Xizhi CEO Dr., Prof.		Ling, Shifeng Quality Manager Doctor		Liu, Yu Product Manager Master, GMP experts
Hu, Zemao Administration Manager Bachelor		Xu, Wei Sales Manager Bachelor		Wang, Bo Clinical Consultant Master
Working staff
Working Environment